Windler E, Beil F-U, Altenburg C, Rinninger F
Endokrinologie und Stoffwechsel des Alterns, Universitätsklinikum Hamburg Eppendorf.
Dtsch Med Wochenschr. 2012 Nov;137(46):2375-9. doi: 10.1055/s-0032-1327259. Epub 2012 Nov 6.
Familial hypercholesterolemia is one of the most common hereditary metabolic disorders, untreated with grave cardiovascular consequences. A general practitioner will see at least one affected individual each month, but will rarely be aware of the diagnosis, though it is easily suspected: an LDL-cholesterol ≥ 190 mg/dl, a family history of premature cardiovascular disease, or clinical signs as arcus lipoides, tendinous xanthomata, or a thickened Achilles' tendon must draw the attention to familial hypercholesterolemia. Because of the burden of high cholesterol levels from childhood on therapy should be initiated early enough, which has become greatly ameliorated since the introduction of statins. In conjunction with additional risk factors, notably low HDL-cholesterol or elevated lipoprotein(a) the cardiovascular sequelae can be dramatic and may call for more intense therapies. However, often the routine of successful cholesterol lowering covers the diagnosis nowadays, so that a heritable metabolic disorder is not suspected, which, however, prevents an effective prevention in relatives, particularly the children of the patient.
家族性高胆固醇血症是最常见的遗传性代谢紊乱疾病之一,若不治疗会导致严重的心血管后果。全科医生每月至少会见到一名受影响的个体,但很少能意识到该诊断,尽管很容易怀疑:低密度脂蛋白胆固醇≥190mg/dl、早发性心血管疾病家族史,或诸如睑黄瘤、肌腱黄色瘤或增厚的跟腱等临床体征,都必须引起对家族性高胆固醇血症的关注。由于儿童期就存在高胆固醇水平的负担,治疗应尽早开始,自他汀类药物问世以来,这一情况已大为改善。结合其他危险因素,尤其是低高密度脂蛋白胆固醇或升高的脂蛋白(a),心血管后遗症可能很严重,可能需要更强化的治疗。然而,如今成功降低胆固醇的常规做法常常掩盖了诊断,以至于不会怀疑存在遗传性代谢紊乱,而这会妨碍对亲属,尤其是患者子女进行有效的预防。